Showing results (911-920 of 930) with videos related to

Sort By:
Pageof 93
Biorxiv : the Preprint Server for Biology|April 16, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
Science Translational Medicine|May 20, 2016
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and miceYusuke Shono, Melissa D Docampo, Jonathan U Peled, et al.
Annals of Translational Medicine|February 13, 2018
Interaction between peri-operative blood transfusion, tidal volume, airway pressure and postoperative ARDS: an individual patient data meta-analysisAry Serpa Neto, Nicole P Juffermans, Sabrine N T Hemmes, et al.
The Journal of Infectious Diseases|July 8, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Journal of Hospital Infection|February 22, 2026
All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multicentre cohort study in six German university hospitals, 2016-2020Anna M Rohde, Winfried V Kern, Michael Behnke, et al.
The Journal of Experimental Medicine|August 17, 2016
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansionMartin Chopra, Marlene Biehl, Tim Steinfatt, et al.
Lancet (London, England)|October 17, 2017
Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysisDavid M Pigott, Aniruddha Deshpande, Ian Letourneau, et al.
Blood|October 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myelomaJan Eckmann, Tanja Fauti, Marlene Biehl, et al.
Nature Communications|June 8, 2021
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosusSarfaraz A Hasni, Sarthak Gupta, Michael Davis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Pageof 93